New Dental Claim For PREVICOX®
14 years ago
5021 views
Posted
5th September, 2011 10h08
An estimated 70% of dogs over 2 years of age may have some degree of periodontal disease1. Extraction of teeth is often necessary for the successful management of this condition and is regarded as a painful procedure. The ability of PREVICOX® to control the pain associated with dental surgery has recently been demonstrated in a double blinded, controlled trial2 in which dogs underwent maxillary canine tooth extraction. The results showed that PREVICOX® treatment significantly reduced pain scores post dental surgery, making it the only NSAID with a specific claim for relief of post-operative dental pain. Results of physical examination and blood testing also confirmed the peri-operative safety profile of PREVICOX®, with no treatment-related adverse effects noted during the trial.
The benefits of PREVICOX®- Licensed for relief of pain and inflammation associated with osteoarthritis and soft tissue, orthopaedic and dental surgery
- The first, and still the most selective, coxib NSAID for dogs
- Rapid absorption means that peak plasma concentrations are reached within 90 minutes
- Safety and efficacy profile confirmed by clinical experience and supported by several published studies
More from
- Vetsure Named Business of the Year at 2025 SME National Business Awards
- Home of hope for Romania's dogs: The pioneering shelter doing things differently
- Pioneering new locum platform transforming veterinary landscape
- Key Stakeholders unite to advance helmet design for equine veterinary professionals
- Hallmarq hails transformational equine imaging technology

3 days ago